Table 1 Clinical features of... | American Society of Hematology

Table 1

Clinical features of HIV-positive individuals

Patient no.	Year of birth	Seroconversion (year)	CDC stage*	CD4⁺ T cells/μL	CD8⁺ T cells/μL	CD4/CD8 ratio	Viremia (RNA copies/mL)
1	1969	1995	C3	131	1223	0.10	386,000
2	1962	1983	C3	210	1479	0.14	42,600
3	1955	1992	C3	215	1507	0.14	≤50
4	1969	1995	C2	327	2244	0.15	12,000
5	1963	1994	C3	238	1129	0.21	156
6	1960	1994	C2	378	1533	0.25	≤50
7	1969	1991	C2	433	921	0.47	≤50
8	1947	1991	C3	116	ND	ND	195,000
9*	1961	1997	A2	360	1041	0.35	18,157
10	1957	1988	A2	267	978	0.27	40,304
11*	1973	2003	A1	474	1062	0.45	135,315
12	1968	1995	C1	1,167	2237	0.52	67,555

Patient no.	Year of birth	Seroconversion (year)	CDC stage*	CD4⁺ T cells/μL	CD8⁺ T cells/μL	CD4/CD8 ratio	Viremia (RNA copies/mL)
1	1969	1995	C3	131	1223	0.10	386,000
2	1962	1983	C3	210	1479	0.14	42,600
3	1955	1992	C3	215	1507	0.14	≤50
4	1969	1995	C2	327	2244	0.15	12,000
5	1963	1994	C3	238	1129	0.21	156
6	1960	1994	C2	378	1533	0.25	≤50
7	1969	1991	C2	433	921	0.47	≤50
8	1947	1991	C3	116	ND	ND	195,000
9*	1961	1997	A2	360	1041	0.35	18,157
10	1957	1988	A2	267	978	0.27	40,304
11*	1973	2003	A1	474	1062	0.45	135,315
12	1968	1995	C1	1,167	2237	0.52	67,555

All individuals, except nos. 9 and 11 (*), were receiving various highly active antiretroviral therapy protocols, including RT and protease inhibitors, at the time of analysis. None of the patients had received either IFN or IL-2-based therapies.

ND indicates not determined.

CDC stage.⁷⁹

View Large

This Feature Is Available To Subscribers Only